Twist Bioscience Corporation
TWST
$119.03
-$6.26-5.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.49% | 57.48% | 61.19% | 62.79% | 61.33% |
| Total Depreciation and Amortization | 1.74% | -11.62% | -18.60% | -23.86% | -31.72% |
| Total Amortization of Deferred Charges | -14.71% | -6.45% | 0.00% | 11.54% | 277.78% |
| Total Other Non-Cash Items | 331.16% | -84.76% | -80.94% | -81.80% | -84.78% |
| Change in Net Operating Assets | -14.74% | -845.44% | -366.79% | -181.80% | -139.80% |
| Cash from Operations | -3.79% | 0.94% | 18.44% | 25.69% | 26.40% |
| Capital Expenditure | -127.83% | -320.65% | -511.68% | -451.69% | -221.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -461.60% | -269.33% | 101.74% | -62.99% | 0.07% |
| Cash from Investing | -231.57% | -796.31% | -278.01% | -706.32% | -238.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.94% | -6.69% | -15.22% | 24.77% | 31.96% |
| Repurchase of Common Stock | 18.18% | 42.31% | 99.23% | 99.60% | 99.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -100.00% | -- | -- |
| Cash from Financing | -48.12% | -57.23% | -58.59% | 314.22% | 617.76% |
| Foreign Exchange rate Adjustments | 232.08% | -24.60% | 576.74% | 13.49% | 960.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.18% | -164.80% | -62.18% | 27.34% | 45.37% |